Unusual symptoms found in cat scratch disease patients

Article

Vitreous haemorrhage with retinal vaculitis and isolated central retinal artery occlusion (CRAO) were reported in the eyes of patients with cat scratch disease

Vitreous haemorrhage with retinal vaculitis and isolated central retinal artery occlusion (CRAO) were reported in the eyes of patients with cat scratch disease (CSD), according to an investigation in International Ophthalmology.

CSD, caused by proteobacterium Bartonella henslae, has presented ocular complications including blurred vision and partial visual loss.

Dr Antonio Pinna et al., St Orsola-Malpighi University Hospital, Italy, investigated the cases of 2 CSD patients. One case involved a 42-year-old patient who had blurred vision for five days, with visual acuity in the right eye at 20/25. Fundus examination demonstrated mild vitreous haemorrhage, diffuse retinal haemorrhage and multiple vasculitic occlusions in the mid-peripheral retina. Immunoglobulin (Ig)M and IgG in B. henslae. Oral anzithromycin was administered for 8 days.

The second case involved a 66-year-old patient with systematic hypertension and hypercholerterolemia and reported visual loss in the left eye. Fluorescein angiography and fundus evaluation revealed CRAO and serologic testing confirmed the presence of IgM and IgG antibodies. The patient was given oral anzithromycin for 6 days.

One month after treatment the patient in case 1 had 20/20 vision in the right eye and the vitreous and retinal haemorrhages were resolved. The patient in case 2 had visual acuity in the left eye to the level of hand motion.

Ophthalmologists should always be aware of unusual ocular manifestations in CSD, especially vitreous haemorrhage with retinal vasculitis and isolated CRAO.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.